Malaria Rapid Diagnostic Tests (RDTs) Market, By Product Type (Detect Only One Species and Detect Multiple Species), By End Users (Hospital, Clinic and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2034

Malaria Rapid Diagnostic Tests Market was valued at US$ 802.2 million in 2024 and is projected to grow at a CAGR of 5.1% to reach US$ 1319.6 million by 2034.

Malaria, a potentially fatal illness by Plasmodium parasites and spread by mosquito bites, continues to be a major global health concern, especially in areas with poor access to modern medical facilities. These parasites then move to red blood cells to reach a stage called merozoites where they grow inside the red cells and kill them. The loss of red blood cells causes symptoms such as fever, tiredness, vomiting and headaches. In addition, the procedures and examinations that are conducted to identify malarial infection are called as malaria diagnostics. An accurate and timely diagnosis is essential for managing and treating malaria effectively. Rapid diagnostic tests (RDTs) for malaria are essential instruments for precisely and promptly identifying malaria infections, especially in places where laboratory facilities are scarce. Because RDTs are easy to use and yield findings quickly, they can be used in a variety of healthcare settings, including places with low resources or remote locations. Malaria Rapid Diagnostic Test(RDTs) detects malaria antigen in blood.

Malaria is life threatening disease occurring mostly in tropical and subtropical region due to changing climate, low economic growth, under-developed healthcare infrastructure. Malaria Rapid diagnostic test plays vital part in controlling malaria by early and proper diagnosis. Declining prices, affordability, and improving product quality to boost the Malaria rapid Diagnostic Tests Market. According to WHO, globally 3.1 billion Malaria RDTs were sold in 2010-2020. UNICEF also provides malaria rapid diagnostic test to control malaria on behalf of various health program.

DRIVERS:

Advantages of Malarial RDTs

Prevalence of malaria is increasing and thus require a proper diagnosis, RDTs are easy to use, and no skillset require to conduct the test, can be performed conveniently anywhere without any infrastructure. Use of RDTs is becoming popular in rural areas where they have limited access to healthcare and being user friendly. It tales 15-20 minutes, cost effective and easily available in the market boosts the malaria rapid diagnostic tests market (RDTs).

Enhancing quality of Rapid diagnostic Kits

Prices are dropping because of the competitive environment, which is anticipated to significantly expand the malaria rapid diagnostic tests market. The procedure is made more transparent by the malaria RDT evaluation program, which was started by the World Health Organization (WHO) and the Foundation for Innovative New Diagnostics (FIND) to make pre-purchase performance evaluation and pre-distribution quality control. Healthcare professionals are placing a greater value on RDTs that comply with WHO standards, which raises the standard of RDTs that manufacturers offer and is expected to support market expansion.

RESTRAINS:

Malaria RDTs may give false-positive or false-negative results due to low parasite load or when not used correctly, inaccurate results may hamper the malaria rapid diagnostic tests market.it can affect the patient’s diagnosis and treatment. This variability might also be due to variation between manufacturers and batches effecting accuracy, consistency, and reliability of the RDTs.

Limited shelf life and maintaining proper storage conditions is still a challenge. Lack awareness regarding malarial disease in rural areas & lack of access to healthcare professionals and healthcare advancements might hamper the growth of malaria rapid diagnostic tests market. Availability of other molecular diagnostic method such as PCR (Polymerase Chain Reaction) which are also quite easily available, affordable, specific, and sensitive might affect the targeted market.

Malaria Rapid Diagnostic Tests Market is segmented based on Product Type, End-User, and Region.

Product Type Insights

On the basis of Product Type, the target market is segmented into Detect Only One Species and Detect Multiple Species. Detect multiple species segment tends to dominate the targeted market. This allows for detection of presence of malarial parasite of different species rather than any specific species. No understanding of local prevalence and distribution is required during selecting the Rapid diagnosis test. Multiple species detection offers a lower risk of missing infection due to less common species.

End-User Insights

On the basis of End User, the target market is segmented into Hospital, Clinic, and Others. Clinic segment holds the largest share in the segment in malaria rapid diagnostic tests market. Increasing focus on the use of RDTs for quick turnaround time, affordability, and ease of access is one of the key factors responsible for the dominance. On time diagnosis and proper diagnosis is very crucial for malaria treatment and reducing complications. Although clinics have low patients, but they lead to improved patient outcomes due to being promptly available and quick diagnosis. Rising awareness allows people to seek proper diagnosis from skilled professionals and clinics hold a major segment of skilled professionals and boosting the malaria rapid diagnostic tests market

Regional Insights

• Africa is estimated to witness a highest revenue share over the forecast period due to increased cases of malaria as Falciparum, most lethal parasite, is most prevalent parasite in this region. According to the WHO, an estimated 92.0% of global malaria cases and 93% of global malarial deaths were recorded in this region, This disease kills an African child every 60 seconds. These facts are indicative of the rising prevalence of malaria in Africa. Therefore, there is a need for early diagnosis of malaria infection in this region, which boosts the growth of the market.
• Asia Pacific market is estimated to witness a fastest revenue share over the forecast period due to advanced technological advancements in healthcare sectors, increase in awareness regarding the use of malaria diagnostics for early diagnosis of the infection for better treatment. The constantly evolving life science industry drives the growth of the market in developing economies such as India, China, and Malaysia, as the constant development leads to surge in awareness related to the use of malaria diagnostics. Boosting the Malaria Rapid Diagnostic Tests Market in the region.

Report Scope:

Attribute	Details
Base year for estimation	2024
Forecast period	2024 – 2034
Market representation	Revenue in USD Billion & CAGR from 2024 to 2034
Market Segmentation	By Product Type – Detect Only One Species and Detect Multiple Species By End-User -  Hospital, Clinic, and Others
Regional scope	North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2024 to 2034.

Malaria Rapid Diagnostic Tests Market, By Product Type:

• Detect Only One Species
• Detect Multiple Species

Malaria Rapid Diagnostic Tests Market, By End-User:

• Hospital
• Clinic
• Others

Malaria Rapid Diagnostic Tests Market, By Region:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Recent Development:

The New Launched Product News,

• In June 2023, GenWorks, a healthcare solution provider, announced the introduction of Invitro Diagnostic tests including Rapid care test kits, iScreen Malaria Card Antigen, for dengue and Malaria. This aimed at preventing, diagnosing, curing and treating seasonal epidemics and thus directs fir proper medications. This is a lateral flow immunoassay for qualitative detection of P.falcipuram.
• In April 2023, Kenya's Ministry of Health on Wednesday announced new strategies that harness sustained funding and innovations in order to eliminate malaria by 2030. Josephine Mburu, principal secretary in the Ministry of Health added that Kenya is continuing to provide prompt malaria diagnosis and treatment through microscopy and the use of quality-assured malaria rapid diagnostic test kits and medicines. Kenya has mobilized 1 million U.S. dollars toward the fight against malaria as part of domestic funding since external funding is either stagnating or declining in an environment of increasing needs.
• In October 2023, Uganda's Ministry of Health revealed that the World Health Organization (WHO) and Uganda Virus Research Institute have given approval to Microheam Scientifics and Medical Supplies to start manufacturing HIV/Aids and Malaria Rapid Diagnostic Kits beginning from November.

Few Other Promising Reports:

• Hydroxychloroquine Market
• Malaria Vaccines Market

The key players operating the Malaria Rapid Diagnostic Tests Market includes Abbott Laboratories (Alere Inc.), Access Bio Inc., Bio-Rad Laboratories Inc., Access Bio Inc., Linde Plc and BioMérieux Inc, Sysmex Partec GmbH, Beckman Coulter, Inc., Siemens Healthineers, Leica Microsystems GmbH, and Nikon Corporation.

"

1. Research Objective and Assumption
   • Preface
   • Research Objectives
   • Study Scope
   • Years Considered for the study
   • Assumptions
   • Abbreviations
2. Research Methodology
   • Research data
   • Primary Data
     • Primary Interviews
     • Primary Breakdown
     • Key data from Primary Sources
     • Key Thickness Insights
   • Secondary Data
     • Major Secondary Sources
     • Secondary Sources
   • Market Estimation
   • Top-Down Approach
     • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
   • Bottom-Up Approach
     • Approach for estimating market share by Bottom-up Analysis (Demand Side)
   • Market Breakdown and Data Triangulation
   • Research Assumptions
   • PORTER’s
   • Investment Outlook
3. Market Purview
   • Executive Summary
   • Key Findings—Global Outlook for Malaria Rapid Diagnostic Tests (RDTS) Strategies
     • Key Questions this Study will Answer

     • • By Product Type (Detect Only One Species and Detect Multiple Species),

       • By End Users (Hospital, Clinic and Others),

       • By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)

   • Opportunity Map Analysis
   • Executive Summary—3 Big Predictions
4. Market Dynamics, Regulations, and Trends Analysis
   • Market Dynamics
     • Drivers
     • Restraints
     • Market Opportunities
     • Market Trends
   • DR Impact Analysis
   • PEST Analysis
   • Porter’s Five Forces Analysis
   • Opportunity Orbit
   • Overview
   • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
   • Y-o-Y Growth Analysis (%), 2020 – 2030
   • Regional Trends
   • Market Investment Feasibility Index
   • Macroeconomic Factor Analysis
5. Regional Analysis
   • Regional Revenue Analysis
   • Regional By segment Analysis
   • Reasons for regional growth
   • Key Player of particular region
   • Countries Include in the report:

1. • • North America (U.S., Canada)
     • Europe (UK, France, Germany, Russia, Italy, Rest of Europe)
     • Asia Pacific (India, Japan, South Korea, China, Rest of Asia Pacific)
     • Latin America (Brazil, Mexico, Rest of Latin America)
     • Middle East & Africa (GCC, Israel, South Africa, Rest of Middle East)

1. Competitive Landscape
   • Heat Map Analysis
   • Market Presence and Specificity Analysis
   • Competitive Overview
   • Competitive Benchmarking
   • Market Share Analysis
   • Key Developments In The Global Malaria Rapid Diagnostic Tests (RDTS) Market
   • Key Developments: Mergers & Acquisitions
   • Key Developments: Collaboration
   • Key Developments: Contracts & Agreements
   • Key Developments: Expansion
   • Key Developments: Product Developments
2. Company Profiles

 

• Company Overview
• Product Portfolio
• Key Highlights
• Financial Performance
• Business Strategies
• SWOT Analysis

• Abbott Laboratories (Alere Inc.), Access Bio Inc., Bio-Rad Laboratories Inc., Access Bio Inc., Linde Plc and BioMérieux Inc, Sysmex Partec GmbH, Beckman Coulter, Inc., Siemens Healthineers, Leica Microsystems GmbH, and Nikon Corporation.

1. The Last Word
   • Future Impact
   • About Us
   • Contact

"